🇺🇸 FDA
Pipeline program

Guselkumab

CR108957

Approved small_molecule active

Quick answer

Guselkumab for Arthritis, Psoriatic is a Approved program (small_molecule) at Janssen Cilag International NV with 3 ClinicalTrials.gov record(s).

Program details

Company
Janssen Cilag International NV
Indication
Arthritis, Psoriatic
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials